The covid-19 pandemic was (and continues to be) one of the most significant crises in recent history, leading to a race against time to develop a safe and effective vaccine.
Global big labs and pharma played a crucial role in this effort, working at an unprecedented pace to get vaccines to market as quickly as possible.
The development and sale of vaccines for the covid had a great impact on the sales and profits of these companies. Many of them saw a significant increase in their revenue thanks to massive demand around the world.
Some, like Pfizer, Moderna and AstraZeneca all posted notable gains especially in 2021 and 2022.
However, it is also important to note that the development and sale of covid vaccines was controversial.
Some argue that these companies made (and continue to make) a lot of money off a global crisis and that they should have done more to ensure that vaccines are available to everyone, not just those who can pay for them.
In addition, there are groups that show concerns about the speed at which vaccines have been developed, as they fear that safety and effectiveness have been sacrificed in exchange for speed.
Moderna’s Vaccines and Revenues
A piece of information that shows the notable sales and profits of these groups comes from the financial results of modern America.
The company said this Monday, January 9, that it generated around 18.4 billion dollars in sales of covid vaccines in 2022, beating their forecasts of between $18,000 and $19,000 for the year.
The company also forecast sales of $4.5 to $5 billion for the same products by 2023.
He also warned that he expects to have more contracts related to his covid vaccine in 2023, which would further increase his income in this way.
Another of the big winners with the covid was Pfizer.
In 2021, the turnover of this pharmaceutical grew brutally: from 42,100 million in 2020 (the year the pandemic began) and 51,000 million (average of the years prior to the coronavirus), moved to total revenue of $81.2 billion in 2021.
We now have to wait for the results of 2022, but everything indicates that they will have grown exponentially again.
Now read:
Zara sells less, but earns more thanks to the price increase
Xiaomi loses millions in an uncertain context for the brand
The crisis does not affect Walmart, which bills more due to inflation and higher demand